EPISODE · Apr 25, 2026 · 1 MIN
CIBRA Capital's Big Bet on Amicus Therapeutics
from The Daily News Now! Business
CIBRA Capitals latest SEC filing reveals a significant investment in Amicus Therapeutics, making it their top holding. They bought 1.48 million shares for $21.2 million, increasing their stake to 1.69 million shares worth $24.4 million. This move comes as Amicus stock surged by 103.7% over the past year, with the company focusing on rare diseases and a potential merger with BioMarin. CIBRAs bet on this merger arbitrage could yield a quick profit or result in significant losses. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/bcb74a973709fd69
NOW PLAYING
CIBRA Capital's Big Bet on Amicus Therapeutics
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m